ACRO Biomedical Co., Ltd.(TW:6748)
NT$169.50+1.00 (+0.59%)
TW:6748
ACRO Biomedical Co., Ltd. Revenue
NT$169.50
At close:+1.00 (+0.59%)
ACRO Biomedical Co., Ltd. (6748) Revenue
ACRO Biomedical Co., Ltd. Revenue
ACRO Biomedical Co., Ltd. had a revenue of 27.82M in the quarter ending Jun 30, 2026, with 100.00%. This bring the company's revenue in the last twelve months to 79.14M, Increased 36.50%. In the fiscal year ending Dec 31, 2025, ACRO Biomedical Co., Ltd. had annual revenue of 38.26M with -13.51% growth.
- Revenue (ttm)
- 79.14M
- Revenue Growth
- 44.54%
- P/S Ratio
- 317.61
- Revenue/Employee
- TWD 910,833
- Employees
- 42
- Market Cap
- TWD 12.15B
Revenue Chart
ACRO Biomedical Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 38.26M | -5.98M | -13.51% |
| Dec 31, 2024 | 44.23M | -6.83M | -13.38% |
| Dec 31, 2023 | 51.06M | 23.43M | 84.79% |
| Dec 31, 2022 | 27.63M | 5.80M | 26.59% |
| Dec 31, 2021 | 21.83M | 3.79M | 21.04% |
| Dec 31, 2020 | 18.03M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.